<DOC>
	<DOCNO>NCT01870687</DOCNO>
	<brief_summary>The purpose study proof efficacy safety 20 mg ( 2 tablet 10 mg ) VAC BNO 1095 film-coated tablet patient suffer cyclic mastodynia PMS ( pre menstrual syndrome ) .</brief_summary>
	<brief_title>Efficacy Safety 20 mg ( 2 Tablets 10mg ) VAC BNO 1095 FCT Cyclic Mastodynia PMS</brief_title>
	<detailed_description>The study consist 2-cycle run-in period , follow 3 cycle treatment . After first screen S-2 visit schedule end first second run-in cycle , first , second third treatment cycle , respectively . At least 220 patient eligible randomisation , 110 treatment group , 160 ( 80 per group ) available data evaluation .</detailed_description>
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<mesh_term>Mastodynia</mesh_term>
	<criteria>Females 18 45 Y history cyclic mastodynia PMS Stable cycle duration 25 35 day . Subject report least one moderate severe physical PMS symptom moderate one psychic symptom , use COPE symptom list Subject reporting symptom total score least 15 late luteal phase precede cycle , use COPE symptom list In runin cycle : Confirmation cyclic mastodynia base daily recording patient diary ( VAS COPE data ) Subject provide negative pregnancy test study start willing use hormonefree medically acknowledge contraception method PEARLindex &lt; 1 % enrolment Unsuspicious breast USG/mammogram old 12 month rule sign malignancy Hypersensitivity active substance excipients IMP Proof PMDD accord DSM IV criterion define APA Intake follow medication treatment start within 6 month prior screen visit : hypothalamic hormone injectable contraceptive : 3month injection Intake follow medication ( include herbal homeopathic drug ) treatment start within 3 month prior screen visit : treatment mastodynia premenstrual complaint sexual hormone , combination inhibitor pituitary hormone inhibitor dopamineagonists dopamineantagonists neuroleptic , antidepressant ( include serotonin serotoninnorepinephrinereuptakeinhibitors ) prolactininhibitors prolactin stimulating preparation drug abuse continuous intake NSAIDs analgetics include antirheumatics ( 2 tablet paracetamol 500 mg equivalent per week allow ) spironolactone gonadotrophin inhibitor diuretic danazol psychotropic agent Any psychiatric treatment treatment start within 12 month prior screen visit Medical history presence follow medical conditions/ disease treatment start : Uncontrolled diabetes mellitus : Patients know diabetes mellitus , glycosylated haemoglobin ( HbA1c ) â‰¥ 7 % assessed visit S1 Uncontrolled hypertension : Patients diastolic blood pressure &gt; 90mmHg visit S2 Known cardiac insufficiency , coronary heart disease , valvular heart disease , cardiac arrhythmia , QT interval prolongation severe cardiac disease visit S2 Known clinically significant organ systemic disease relevant medical condition opinion investigator , significance disease condition compromise subject 's participation study Known hyperprolactinemia ( serum prolactin basal &gt; 50 ng/ml &gt; 1050 mlU/L ) Known hypo/hyperthyreosis Known hypo/hyperparathyroidism Known pituitary tumor include prolactinoma Known chronic kidney disease Known gastrointestinal , liver disease , : i. active peptic gastric ulcer ii . malabsorption iii . hepatitis endometriosis breast cancer , fibroadenoma , intraductal papilloma malignancy within last 10 year suspicious nonverified find breast ultrasound mammogram past galactorrhea degree II III purulent bloody nipple discharge refractory and/or unverified breast skin nipple/areola lesion pregnancy , lactation wish pregnancy surgery plan take place trial include breast cyst puncture Values safety laboratory parameter outside normal range clinically relevant assessed investigator S1 At screening : TSH &gt; 2.5 mU/L Patients difficulty understand language patient information give Patients member staff study centre , staff sponsor CRO , investigator close relative investigator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>vitex agnus castus</keyword>
	<keyword>clinical trial</keyword>
	<keyword>cyclic mastodynia</keyword>
	<keyword>PMS</keyword>
	<keyword>prospective</keyword>
</DOC>